{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:34:51Z","timestamp":1785296091290,"version":"3.55.0"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"crossref","award":["CDC-RFA-CK17-1701"],"award-info":[{"award-number":["CDC-RFA-CK17-1701"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Invasive mold diseases (IMDs) cause severe illness, but public health surveillance data are lacking. We describe data collected from a laboratory-based, pilot IMD surveillance system.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>During 2017\u20132019, the Emerging Infections Program conducted active IMD surveillance at 3 Atlanta-area hospitals. We ascertained potential cases by reviewing histopathology, culture, and Aspergillus galactomannan results and classified patients as having an IMD case (based on European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group [MSG] criteria) or a non-MSG IMD case (based on the treating clinician\u2019s diagnosis and use of mold-active antifungal therapy). We described patient features and compared patients with MSG vs non-MSG IMD cases.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 304 patients with potential IMD, 104 (34.2%) met an IMD case definition (41 MSG, 63 non-MSG). The most common IMD types were invasive aspergillosis (n\u2009=\u200966 [63.5%]), mucormycosis (n\u2009=\u20098 [7.7%]), and fusariosis (n\u2009=\u20094 [3.8%]); the most frequently affected body sites were pulmonary (n\u2009=\u200966 [63.5%]), otorhinolaryngologic (n\u2009=\u200917 [16.3%]), and cutaneous\/deep tissue (n\u2009=\u20099 [8.7%]). Forty-five (43.3%) IMD patients received intensive care unit\u2013level care, and 90-day all-cause mortality was 32.7%; these outcomes did not differ significantly between MSG and non-MSG IMD patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>IMD patients had high mortality rates and a variety of clinical presentations. Comprehensive IMD surveillance is needed to assess emerging trends, and strict application of MSG criteria for surveillance might exclude over one-half of clinically significant IMD cases.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ofid\/ofac215","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T07:01:12Z","timestamp":1650524472000},"source":"Crossref","is-referenced-by-count":14,"title":["Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease\u2014Georgia, United States, 2017\u20132019"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5054-7616","authenticated-orcid":false,"given":"Jeremy A W","family":"Gold","sequence":"first","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Revis","sequence":"additional","affiliation":[{"name":"Atlanta Veterans Affairs Medical Center , Atlanta, Georgia , USA"},{"name":"Georgia Emerging Infections , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stepy","family":"Thomas","sequence":"additional","affiliation":[{"name":"Atlanta Veterans Affairs Medical Center , Atlanta, Georgia , USA"},{"name":"Georgia Emerging Infections , Atlanta, Georgia , USA"},{"name":"Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewis","family":"Perry","sequence":"additional","affiliation":[{"name":"Atlanta Veterans Affairs Medical Center , Atlanta, Georgia , USA"},{"name":"Georgia Emerging Infections , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah A","family":"Blakney","sequence":"additional","affiliation":[{"name":"Atlanta Veterans Affairs Medical Center , Atlanta, Georgia , USA"},{"name":"Georgia Emerging Infections , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Chambers","sequence":"additional","affiliation":[{"name":"Atlanta Veterans Affairs Medical Center , Atlanta, Georgia , USA"},{"name":"Georgia Emerging Infections , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan L","family":"Bentz","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth L","family":"Berkow","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn R","family":"Lockhart","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Lysen","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie S","family":"Nunnally","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Jordan","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary C","family":"Kelly","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro J","family":"Montero","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M","family":"Farley","sequence":"additional","affiliation":[{"name":"Atlanta Veterans Affairs Medical Center , Atlanta, Georgia , USA"},{"name":"Georgia Emerging Infections , Atlanta, Georgia , USA"},{"name":"Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora T","family":"Oliver","sequence":"additional","affiliation":[{"name":"Atlanta Veterans Affairs Medical Center , Atlanta, Georgia , USA"},{"name":"Georgia Emerging Infections , Atlanta, Georgia , USA"},{"name":"Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M","family":"Pouch","sequence":"additional","affiliation":[{"name":"Georgia Emerging Infections , Atlanta, Georgia , USA"},{"name":"Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S","family":"Webster","sequence":"additional","affiliation":[{"name":"Atlanta Veterans Affairs Medical Center , Atlanta, Georgia , USA"},{"name":"Georgia Emerging Infections , Atlanta, Georgia , USA"},{"name":"Department of Medicine, Emory University School of Medicine , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan R","family":"Jackson","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlyn D","family":"Beer","sequence":"additional","affiliation":[{"name":"Mycotic Diseases Branch, Centers for Disease Control and Prevention , Atlanta, Georgia , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"key":"2022073010015193200_ofac215-B1","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2022073010015193200_ofac215-B2","doi-asserted-by":"crossref","first-page":"XXX","DOI":"10.1093\/ofid\/ofy187","article-title":"Epidemiology and clinical features of invasive fungal infection in a US health care network","volume":"5","author":"Webb","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2022073010015193200_ofac215-B3","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022073010015193200_ofac215-B4","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/cid\/ciy776","article-title":"Estimation of direct healthcare costs of fungal diseases in the United States","volume":"68","author":"Benedict","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2022073010015193200_ofac215-B5","doi-asserted-by":"crossref","first-page":"i5","DOI":"10.1093\/jac\/dkx028","article-title":"Changes in the epidemiological landscape of invasive mould infections and disease","volume":"72","author":"Lass-Fl\u00f6rl","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2022073010015193200_ofac215-B6","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.3201\/eid1710.110087","article-title":"Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001\u20132006","volume":"17","author":"Park","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"2022073010015193200_ofac215-B7","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1086\/651262","article-title":"Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET)","volume":"50","author":"Pappas","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022073010015193200_ofac215-B8","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022073010015193200_ofac215-B9","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.3109\/13693786.2010.505204","article-title":"Clinical risk factors for invasive aspergillosis","volume":"49","author":"Baddley","year":"2011","journal-title":"Med Mycol"},{"key":"2022073010015193200_ofac215-B10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1469-0691.2009.02974.x","article-title":"Clinical presentation of zygomycosis","volume":"15","author":"Mantadakis","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"2022073010015193200_ofac215-B11","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1093\/cid\/cir865","article-title":"Pathogenesis of mucormycosis","volume":"54","author":"Ibrahim","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2022073010015193200_ofac215-B12","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.3201\/eid2705.204412","article-title":"COVID-19-associated mold infection in critically ill patients, Chile","volume":"27","author":"Rabagliati","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2022073010015193200_ofac215-B13","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.3201\/eid2709.210934","article-title":"Multicenter epidemiologic study of coronavirus disease-associated mucormycosis, India","volume":"27","author":"Patel","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2022073010015193200_ofac215-B14","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1007\/s00134-020-06091-6","article-title":"Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion","volume":"46","author":"Verweij","year":"2020","journal-title":"Intensive Care Med"},{"key":"2022073010015193200_ofac215-B15","doi-asserted-by":"crossref","first-page":"XXX","DOI":"10.1093\/ofid\/ofab091","article-title":"Invasive aspergillosis after influenza and other viral respiratory infections among intensive care unit patients in a commercially insured population in the United States, 2013\u20132018","volume":"8","author":"Toda","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2022073010015193200_ofac215-B16","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.15585\/mmwr.mm7050a3","article-title":"Notes from the field: COVID-19-associated mucormycosis - Arkansas, July-September 2021","volume":"70","author":"Dulski","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022073010015193200_ofac215-B17","doi-asserted-by":"crossref","first-page":"XXX","DOI":"10.1093\/ofid\/ofw268","article-title":"Trends in hospitalizations related to invasive aspergillosis and mucormycosis in the United States, 2000\u20132013","volume":"4","author":"Vallabhaneni","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2022073010015193200_ofac215-B18","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1001\/jama.2016.16477","article-title":"Prevalence of immunosuppression among US adults, 2013","volume":"316","author":"Harpaz","year":"2016","journal-title":"JAMA"},{"key":"2022073010015193200_ofac215-B19","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.diagmicrobio.2018.06.009","article-title":"Liquid biopsy for infectious diseases: sequencing of cell-free plasma to detect pathogen DNA in patients with invasive fungal disease","volume":"92","author":"Hong","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2022073010015193200_ofac215-B20","doi-asserted-by":"crossref","first-page":"i19","DOI":"10.1093\/jac\/dkx030","article-title":"Early diagnosis of invasive mould infections and disease","volume":"72","author":"Lamoth","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"2022073010015193200_ofac215-B21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3390\/jof5030069","article-title":"A guide to investigating suspected outbreaks of mucormycosis in healthcare","volume":"5","author":"Hartnett","year":"2019","journal-title":"J Fungi (Basel)"},{"key":"2022073010015193200_ofac215-B22","first-page":"553","volume-title":"Essentials of Clinical Mycology","author":"Park","year":"2011"},{"key":"2022073010015193200_ofac215-B23","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC definitions of invasive fungal diseases: summary of activities of the intensive care unit working group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2022073010015193200_ofac215-B24","article-title":"About EIP","author":"Centers for Disease Control and Prevention"},{"key":"2022073010015193200_ofac215-B25","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/13693780802609604","article-title":"Occurrence and relevance of filamentous fungi in respiratory secretions of patients with cystic fibrosis\u2014a review","volume":"47","author":"Pihet","year":"2009","journal-title":"Med Mycol"},{"key":"2022073010015193200_ofac215-B26","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1128\/JCM.01000-13","article-title":"Preliminary laboratory report of fungal infections associated with contaminated methylprednisolone injections","volume":"51","author":"Lockhart","year":"2013","journal-title":"J Clin Microbiol"},{"key":"2022073010015193200_ofac215-B27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/myc.13249","article-title":"Performance evaluation of fungal DNA PCR amplification from formalin-fixed paraffin-embedded tissue for diagnosis: experience of a tertiary reference laboratory","volume":"64","author":"Lysen","year":"2021","journal-title":"Mycoses"},{"key":"2022073010015193200_ofac215-B28","doi-asserted-by":"crossref","first-page":"e02240-17","DOI":"10.1128\/AAC.02240-17","article-title":"Detection of TR(34)\/L98H CYP51A mutation through passive surveillance for azole-resistant Aspergillus fumigatus in the United States from 2015 to 2017","volume":"62","author":"Berkow","year":"2018","journal-title":"Antimicrob Agents chemother"},{"key":"2022073010015193200_ofac215-B29","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.15585\/mmwr.mm6738a5","article-title":"Multidrug-resistant Aspergillus fumigatus carrying mutations linked to environmental fungicide exposure - three states, 2010\u20132017","volume":"67","author":"Beer","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2022073010015193200_ofac215-B30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1086\/421950","article-title":"Infections due to Aspergillus terreus: a multicenter retrospective analysis of 83 cases","volume":"39","author":"Steinbach","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2022073010015193200_ofac215-B31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1439-0507.2008.01642.x","article-title":"Aspergillus flavus: an emerging non-fumigatus Aspergillus species of significance","volume":"52","author":"Krishnan","year":"2009","journal-title":"Mycoses"},{"key":"2022073010015193200_ofac215-B32","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/JCM.00854-09","article-title":"Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network","volume":"47","author":"Baddley","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2022073010015193200_ofac215-B33","doi-asserted-by":"crossref","first-page":"e01244-19","DOI":"10.1128\/AAC.01244-19","article-title":"Therapeutic challenges of non-Aspergillus invasive mold infections in immunosuppressed patients","volume":"63","author":"Lamoth","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"2022073010015193200_ofac215-B34","doi-asserted-by":"crossref","first-page":"e246","DOI":"10.1016\/S1473-3099(20)30784-2","article-title":"Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology","volume":"21","author":"Hoenigl","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2022073010015193200_ofac215-B35","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1086\/652761","article-title":"Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation","volume":"50","author":"Panackal","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2022073010015193200_ofac215-B36","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1093\/cid\/ciaa007","article-title":"High rates of influenza-associated invasive pulmonary aspergillosis may not be universal: a retrospective cohort study from Alberta, Canada","volume":"71","author":"Schwartz","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2022073010015193200_ofac215-B37","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.3201\/eid2711.211174","article-title":"Multinational observational cohort study of COVID-19-associated pulmonary aspergillosis","volume":"27","author":"Janssen","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"2022073010015193200_ofac215-B38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S2213-2600(21)00442-2","article-title":"Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study","volume":"10","author":"Gangneux","year":"2022","journal-title":"Lancet Respir Med"},{"key":"2022073010015193200_ofac215-B39","doi-asserted-by":"crossref","first-page":"S60","DOI":"10.1093\/mmy\/myx091","article-title":"Diagnosis of aspergillosis by PCR: clinical considerations and technical tips","volume":"56","author":"Barnes","year":"2018","journal-title":"Med Mycol"},{"key":"2022073010015193200_ofac215-B40","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1080\/13693780600904918","article-title":"Issues with galactomannan testing","volume":"44","author":"Verweij","year":"2006","journal-title":"Med Mycol"},{"key":"2022073010015193200_ofac215-B41","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/myc.12927","article-title":"Invasive aspergillosis in critically ill patients: an autopsy study","volume":"62","author":"Tejerina","year":"2019","journal-title":"Mycoses"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofac215\/43404745\/ofac215.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/7\/ofac215\/45028880\/ofac215.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/7\/ofac215\/45028880\/ofac215.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T10:04:27Z","timestamp":1659175467000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofac215\/6571701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofac215","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,4,21]]},"article-number":"ofac215"}}